RUNDC1 anticorps (C-Term)
Aperçu rapide pour RUNDC1 anticorps (C-Term) (ABIN954643)
Antigène
Voir toutes RUNDC1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 508-537, C-Term
-
Specificité
- Recognizes RUNDC1 (C-term).
-
Purification
- Protein A column followed by peptide Affinity purification
-
Immunogène
- KLH conjugated synthetic peptide between 508-537 amino acids from the C-terminal region of Human RUNDC1 Genename: RUNDC1
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- RUNDC1 (RUN Domain Containing 1 (RUNDC1))
-
Autre désignation
- RUNDC1
-
Sujet
- RUNDC1 may play a role as p53/TP53 inhibitor and thus may have oncogenic activity.Synonyms: LP5161, RUN domain-containing protein 1
-
ID gène
- 146923
-
NCBI Accession
- NP_775102
Antigène
-